| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.003 |